Barbara Melosky

Barbara Melosky

UNVERIFIED PROFILE

Are you Barbara Melosky?   Register this Author

Register author
Barbara Melosky

Barbara Melosky

Publications by authors named "Barbara Melosky"

Are you Barbara Melosky?   Register this Author

35Publications

633Reads

29Profile Views

PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer.

Lung Cancer 2019 Oct 1;136:1-5. Epub 2019 Aug 1.

Department of Pathology, BC Cancer Vancouver Centre, University of British Columbia, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.07.033DOI Listing
October 2019

Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort.

Clin Lung Cancer 2019 Sep 11;20(5):e576-e583. Epub 2019 May 11.

Department of Medical Oncology, BC Cancer, Vancouver Centre, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304193010
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2019.05.003DOI Listing
September 2019

Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.

Lung Cancer 2019 Aug 29;134:259-267. Epub 2019 May 29.

Cross Cancer Institute and University of Alberta, 11560 University Ave, Edmonton, AB, T6G 1Z2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.027DOI Listing
August 2019

Amplifying Outcomes: Checkpoint Inhibitor Combinations in First-Line Non-Small Cell Lung Cancer.

Oncologist 2019 May 28. Epub 2019 May 28.

Cross Cancer Institute and Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2019-0027DOI Listing
May 2019

An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach.

Clin Lung Cancer 2018 01 8;19(1):42-50. Epub 2017 Jun 8.

UC Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.05.019DOI Listing
January 2018

Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer.

Arch Pathol Lab Med 2018 Jan 9;142(1):26-34. Epub 2017 Nov 9.

From the Department of Pathology, University of Ottawa, Ottawa, Ontario, Canada (Dr Marginean); the Gastrointestinal Pathology Section, The Ottawa Hospital, Ottawa (Dr Marginean); the Department of Medical Oncology, University of British Columbia, Vancouver, Canada (Dr Melosky); and the Department of Oncology, British Columbia Cancer Agency, Vancouver (Dr Melosky).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0041-RADOI Listing
January 2018

Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.

Arch Pathol Lab Med 2018 Jan 16;142(1):17-25. Epub 2017 Nov 16.

From the Department of Pathology, University of Ottawa, Ottawa, Ontario, Canada (Dr Marginean); the Gastrointestinal Pathology Section, Ottawa Hospital, Ottawa (Dr Marginean); the Department of Medical Oncology, University of British Columbia, Vancouver, Canada (Dr Melosky); and the Department of Oncology, British Columbia Cancer Agency, Vancouver (Dr Melosky).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0040-RADOI Listing
January 2018

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine.

Authors:
Barbara Melosky

Front Oncol 2017 13;7:311. Epub 2017 Dec 13.

University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2017.00311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733540PMC
December 2017

Low Grade Neuroendocrine Tumors of the Lung.

Authors:
Barbara Melosky

Front Oncol 2017 13;7:119. Epub 2017 Jun 13.

Medical Oncology, British Columbia Cancer Agency - Vancouver Centre, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fonc.2017.001
Publisher Site
http://dx.doi.org/10.3389/fonc.2017.00119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468804PMC
June 2017

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer.

Authors:
Barbara Melosky

Front Oncol 2017 20;7:38. Epub 2017 Mar 20.

Medical Oncology, British Columbia Cancer Agency, Vancouver Centre , Vancouver, BC , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2017.00038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357779PMC
March 2017

Meeting An Unmet Need in Metastatic Colorectal Carcinoma with Regorafenib.

Authors:
Barbara Melosky

Asia Pac J Oncol Nurs 2016 Jan-Mar;3(1):58-65

British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2347-5625.178174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123549PMC
December 2016

Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition.

J Clin Oncol 2016 05 16;34(14):1676-88. Epub 2016 Feb 16.

Barbara Melosky, British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia; Quincy Chu, Cross Cancer Institute and University of Alberta, Edmonton, Alberta; Rosalyn Juergens, McMaster University, Juravinski Cancer Centre, Hamilton; Natasha Leighl, Princess Margaret Hospital and University of Toronto; Deanna McLeod, Kaleidoscope Strategic, Toronto, Ontario; and Vera Hirsh, Montreal General Hospital, Royal Victoria Hospital, and McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.8049DOI Listing
May 2016

Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.

J Clin Oncol 2016 Mar 16;34(8):810-5. Epub 2015 Nov 16.

Barbara Melosky, Vincent Ho, Cheryl Ho, Nevin Murray, Sophie Sun, and Janessa J. Laskin, British Columbia Cancer Agency (BCCA) Vancouver Centre, Vancouver; Helen Anderson, BCCA Vancouver Island Centre, Victoria; Wendy Lam, Burnaby Regional Hospital, Burnaby; Christopher W. Lee, BCCA Fraser Valley Cancer Centre, Surrey; Robert Winston, BCCA Abbotsford Centre, Abbotsford, British Columbia; Ronald L. Burkes, Mount Sinai Hospital; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario; Quincy Chu, Cross Cancer Institute, Edmonton; and Desiree Hao, Tom Baker Care Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.3918DOI Listing
March 2016

Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.

Clin Colorectal Cancer 2015 Mar 4;14(1):25-30. Epub 2014 Nov 4.

Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2014.10.002DOI Listing
March 2015

Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.

Lung Cancer 2014 Dec 2;86(3):344-9. Epub 2014 Oct 2.

Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6 Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.09.016DOI Listing
December 2014

Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFR-TKIs.

Front Oncol 2014 16;4:238. Epub 2014 Sep 16.

Department of Medical Oncology, McGill University Health Centre, Royal Victoria Hospital , Montreal, QC , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165207PMC
October 2014

Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials.

Authors:
Barbara Melosky

Front Oncol 2014 15;4:244. Epub 2014 Sep 15.

Medical Oncology, British Columbia Cancer Agency - Vancouver Centre , Vancouver, BC , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164005PMC
October 2014

Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer.

Authors:
Barbara Melosky

Front Oncol 2014 29;4:256. Epub 2014 Sep 29.

Medical Oncology, British Columbia Cancer Agency - Vancouver Centre , Vancouver, BC , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178375PMC
October 2014

Less toxic chemotherapy improves uptake of all lines of chemotherapy in advanced non-small-cell lung cancer: a 10-year retrospective population-based review.

J Thorac Oncol 2014 Aug;9(8):1180-6

*Medical Oncology, BC Cancer Agency, Vancouver, BC; and †Department of Statistics, University of British Columbia, Vancouver, BC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000225DOI Listing
August 2014

Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysis.

Lung Cancer 2012 Jun 9;76(3):472-7. Epub 2012 Jan 9.

Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.12.003DOI Listing
June 2012

EURTAC first line therapy for non small cell lung carcinoma in epidermal growth factor receptor mutation positive patients: A choice between two TKIs.

Authors:
Barbara Melosky

J Thorac Dis 2012 Apr;4(2):221-2

British Columbia CancerAgency Vancouver Center, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2012.03.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378230PMC
April 2012

Erlotinib or docetaxel for second-line treatment of non-small cell lung cancer: a real-world cost-effectiveness analysis.

J Thorac Oncol 2011 Dec;6(12):2097-103

Canadian Centre for Applied Research in Cancer Control (ARCC), University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31822f657aDOI Listing
December 2011

Don't jump to rash conclusions.

Cancer Biol Ther 2011 Apr 1;11(7):639-41. Epub 2011 Apr 1.

Translational Research Laboratory, Medical Oncologist, Tom Baker Cancer Centre and University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.11.7.14920DOI Listing
April 2011

Shifting the paradigm for maintenance therapy in advanced non-small-cell lung cancer.

Authors:
Barbara Melosky

Lung Cancer (Auckl) 2010 5;1:53-62. Epub 2010 Jun 5.

University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312468PMC
June 2010

Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer: a population-based study.

J Oncol Pract 2009 Jul;5(4):153-8

Division of Medical Oncology; and Population and Preventive Oncology, British Columbia Cancer Agency, Vancouver; and Division of Medical Oncology, British Columbia Cancer Agency, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.0942001
Publisher Site
http://dx.doi.org/10.1200/JOP.0942001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795424PMC
July 2009

Use of random skin biopsy to diagnose intravascular lymphoma presenting as fever of unknown origin.

Am J Med 2003 Jan;114(1):56-8

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0002-9343(02)01378-5DOI Listing
January 2003